One-Step, Wash-free, Nanoparticle Clustering-Based Magnetic Particle Spectroscopy Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in the Liquid Phase
Kai Wu,Vinit Kumar Chugh,Venkatramana D. Krishna,Arturo di Girolamo,Yongqiang Andrew Wang,Renata Saha,Shuang Liang,Maxim C-J Cheeran,Jian-Ping Wang
DOI: https://doi.org/10.1021/acsami.1c14657
2021-09-09
Abstract:With the ongoing global pandemic of coronavirus disease 2019 (COVID-19), there is an increasing quest for more accessible, easy-to-use, rapid, inexpensive, and high-accuracy diagnostic tools. Traditional disease diagnostic methods such as qRT-PCR (quantitative reverse transcription-PCR) and ELISA (enzyme-linked immunosorbent assay) require multiple steps, trained technicians, and long turnaround time that may worsen the disease surveillance and pandemic control. In sight of this situation, a rapid, one-step, easy-to-use, and high-accuracy diagnostic platform will be valuable for future epidemic control, especially for regions with scarce medical resources. Herein, we report a magnetic particle spectroscopy (MPS) platform for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) biomarkers: spike and nucleocapsid proteins. This technique monitors the dynamic magnetic responses of magnetic nanoparticles (MNPs) and uses their higher harmonics as a measure of the nanoparticles' binding states. By anchoring polyclonal antibodies (pAbs) onto MNP surfaces, these nanoparticles function as nanoprobes to specifically bind to target analytes (SARS-CoV-2 spike and nucleocapsid proteins in this work) and form nanoparticle clusters. This binding event causes detectable changes in higher harmonics and allows for quantitative and qualitative detection of target analytes in the liquid phase. We have achieved detection limits of 1.56 nM (equivalent to 125 fmole) and 12.5 nM (equivalent to 1 pmole) for detecting SARS-CoV-2 spike and nucleocapsid proteins, respectively. This MPS platform combined with the one-step, wash-free, nanoparticle clustering-based assay method is intrinsically versatile and allows for the detection of a variety of other disease biomarkers by simply changing the surface functional groups on MNPs.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c14657.Static magnetic hysteresis loops and magnetic properties of IPG30 MNPs; minimum detectable amount of IPG30 by the homebuilt MPS system; hydrodynamic size, zeta potential, and the 3rd harmonic amplitudes of bare MNPs and MNPs functionalized with different amounts of pAbs; grayscale heatmaps of the higher harmonic signal drop Δ (in %) compared to bare MNPs for SARS-CoV-2 spike proteins; grayscale heatmaps of the higher harmonic signal drop n (in %) compared to bare MNPs for SARS-CoV-2 nucleocapsid proteins; ratios of higher harmonics to the 3rd harmonics recorded from Groups I to IV for the SARS-CoV-2 nucleocapsid protein; and specificity of the SARS-CoV-2 spike and nucleocapsid pAbs confirmed by ELISA (PDF)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology